Related Experiment Video
Updated: Jul 15, 2025

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region
Salem H Alshemmari1, Mustaqeem A Siddiqui2,3, Ramesh Pandita4
1Department of Medicine, Faculty of Medicine and Department of Hematology, Kuwait Cancer Control Centre, Shuwaikh, Kuwait.
This consensus provides expert guidance on chronic lymphocytic leukemia (CLL) diagnosis, staging, and treatment, addressing the need for regional guidelines. It synthesizes current literature and expert opinion to improve patient care for this incurable disease.
Area of Science:
- Hematology
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) remains largely incurable despite advances.
- Lack of regional consensus guidelines leads to variable patient management practices.
Purpose of the Study:
- To establish expert consensus on CLL definitions, classifications, and management practices.
- To provide guidance for healthcare professionals managing CLL patients.
- To serve as a foundation for developing regional CLL guidelines.
Main Methods:
- Modified Delphi consensus methodology employed.
- Eight hematology experts responded to 50 statements.
- Consensus reached with >=75% agreement.
Main Results:
- Consensus achieved on nearly all 50 statements covering CLL diagnosis, staging, risk assessment, treatment, and complications.
- Discussions included prognostic evaluation, therapy sequences, and management during the COVID-19 pandemic.
Conclusions:
- The consensus synthesizes decades of principles, new research, and future prospects in CLL management.
- It aims to standardize and improve the care of CLL patients through expert-driven recommendations.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Pancreatitis II: Collaborative Care
Assessment:
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...